Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A new international consensus statement, backed by 20+ medical societies, recommends screening children for early-stage type 1 diabetes (T1D) at ages 2–4, 6–8, and 10–15 — but only if the right infrastructure is in place first. The goal: catch T1D before symptoms strike, reduce dangerous complications like diabetic ketoacidosis, and open doors to preventive therapies. Not all major organizations are aligned on universal screening just yet.
A new international consensus statement, published in Diabetologia and endorsed by over 20 medical societies, is calling for general population screening of children for early-stage type 1 diabetes (T1D). Convened by Breakthrough T1D, the guidance recommends screening at ages 2–4, 6–8, and 10–15, with catch-up screening available at any age. The key caveat: infrastructure — including confirmatory testing, monitoring systems, psychosocial support, and referral pathways — must be in place before screening begins.
The rationale is compelling: roughly 85% of people diagnosed with T1D have no family history, meaning family-only screening misses the vast majority. Early detection could prevent life-threatening diabetic ketoacidosis at diagnosis and enable access to therapies like teplizumab (Tzield), which can delay the onset of clinical T1D.
Key Takeaways:
Why it matters: Early T1D detection could transform outcomes for millions of children — but only if health systems are ready to support those who screen positive.
